Previous 10 | Next 10 |
home / stock / ecl / ecl articles
L'Air Liquide S.A (OTC: AIQUY) has initiated a new Group transformation initiative to foster agility and improve efficiency using its ADVANCE s...
GE HealthCare Technologies Inc. (NASDAQ: GEHC), along with Heart Hospital of New Mexico at Lovelace Medical Center (HHNM), announced HHNM as the fi...
The Mosaic Company (NYSE: MOS) disclosed its combined sales volumes and revenues by business unit for April and May 2024. During this period, potas...
BASF SE (OTC: BASFY) and Encina Development Group, LLC, an ISCC PLUS certified circular chemicals manufacturer, announced a long-term supply agreem...
McKesson Corporation's (NYSE: MCK) Biologics by McKesson, its independent specialty pharmacy specializing in oncology and rare disease areas, h...
BrainsWay Ltd. (NASDAQ: BWAY) recently signed an exclusive multi-year distribution agreement with a specialty distributor serving both the acute ho...
Suzano S.A. (NYSE: SUZ) announced that it acquired a 15% stake in Lenzing (OTC: LNZNF) from its current majority stakeholder, B&C Group. T...
Carpenter Technology Corporation (NYSE: CRS) has been gaining from strong demand in its markets, cost-cutting initiatives and efforts to preserve l...
Comstock Inc. (AMEX:LODE) announced revisions to its agreements with RenFuel K2B AB regarding the development of RenFuel's previously planned b...
News, Short Squeeze, Breakout and More Instantly...
DELRAY BEACH, Fla., July 17, 2024 (GLOBE NEWSWIRE) -- BioProcess360 Partners today announced the launch of a new investment fund to support businesses with the growth of emerging tools and technologies used in the bioprocessing of traditional mAbs and newer drug modalities. BioProcess360 Partners...
Ecolab Inc. (NYSE: ECL) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 2.2% on the day to $243.43. Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internatio...
2024-07-08 06:00:05 ET Shlomo Rosenbaum from Stifel Nicolaus issued a price target of $283.00 for ECL on 2024-07-08 05:06:00. The adjusted price target was set to $283.00. At the time of the announcement, ECL was trading at $238.19. The overall price target consensus is ...